Created at Source Raw Value Validated value
July 20, 2022, noon usa

[{"arm_notes": "nan", "treatment_id": null, "treatment_name": "COVID-19 Vaccine (Vero Cell), Inactivated", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "COVID-19 Vaccine (Vero Cell), Inactivated", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "COVID-19 Vaccine (Vero Cell), Inactivated", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Recombinant COVID-19 Vaccine (Sf9 Cell)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Recombinant COVID-19 Vaccine (Sf9 Cell)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "nan", "treatment_id": null, "treatment_name": "Recombinant COVID-19 Vaccine (Sf9 Cell)", "treatment_type": "Biological", "pharmacological_treatment": "Non pharmacological treatment"}]

[{"arm_notes": "2 doses of Inactivated COVID-19 vaccines with the second dose at least 6 months (\u2265180 days) prior to enrolment", "treatment_id": 1923, "treatment_name": "Inactivated sars-cov-2 vaccine (vero cell)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2 doses of Inactivated COVID-19 vaccines with the second dose at least 6 months (\u2265180 days) prior to enrolment", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2 doses of mRNA COVID-19 vaccines with the second dose at least 6 months (\u2265180 days) prior to enrolment", "treatment_id": 1923, "treatment_name": "Inactivated sars-cov-2 vaccine (vero cell)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2 doses of mRNA COVID-19 vaccines with the second dose at least 6 months (\u2265180 days) prior to enrolment", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2 doses of Viral Vector COVID-19 vaccines with the second dose at least 6 months (\u2265180 days) prior to enrolment", "treatment_id": 1923, "treatment_name": "Inactivated sars-cov-2 vaccine (vero cell)", "treatment_type": "Inactivated virus", "pharmacological_treatment": "Vaccine"}, {"arm_notes": "2 doses of Viral Vector COVID-19 vaccines with the second dose at least 6 months (\u2265180 days) prior to enrolment", "treatment_id": 1089, "treatment_name": "Recombinant sars-cov-2 vaccine (sf9 cell)", "treatment_type": "Protein subunit", "pharmacological_treatment": "Vaccine"}]